{
    "title": "FTSE-250 firm PureTech tumbles 15% as it confirms takeover talks with US drug developer Nektar Therapeutics",
    "url": "https://www.dailymail.co.uk/money/markets/article-11290489/PureTech-confirms-takeover-talks-drug-developer-Nektar-Therapeutics.html",
    "date": "2022-10-07",
    "keywords": [
        "share",
        "puretech",
        "drug",
        "offer",
        "fund",
        "health",
        "ftse",
        "firm",
        "pipeline",
        "cent",
        "company",
        "investment",
        "account",
        "fee",
        "developer",
        "nektar",
        "takeover",
        "offerthe",
        "biotechnology",
        "nonbinding",
        "combination",
        "pricing",
        "certainty",
        "ibs",
        "range",
        "fibrosis",
        "depression",
        "morning",
        "trading",
        "stock",
        "nasdaq",
        "year",
        "business",
        "september",
        "cap",
        "article",
        "group",
        "end",
        "august",
        "index",
        "review",
        "casualty",
        "approach",
        "half",
        "period",
        "yearin",
        "portion",
        "stake",
        "biotech",
        "saleat",
        "time",
        "growth",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}